Advertisement

Topics

Takeda Pharma GmbH Company Profile

14:09 EST 17th December 2018 | BioPortfolio

Nil

Location

Viktoriaallee 3 - 5
Aachen
D-52066
Germany

Contact

Phone: 0241 941-0
Fax: 0241 941-2769
Email: info@takeda.de


News Articles [1114 Associated News Articles listed on BioPortfolio]

Takeda finalises buyout of TiGenix

Japanese pharma giant Takeda has completed its buyout of TiGenix. Takeda’s main R&D focus is in oncology, gastroenterology and neuroscience therapeutic areas, and vaccines. The company employs ...

Takeda Research Investment: Reaching Beyond the Land of the Rising Sun

This insightful conversation features Graeme Martin, CEO of Takeda Research Investment (TRI) the corporate venture arm of Takeda Pharmaceutical, the largest pharma company in Japan and among the large...

Takeda Family Member Speaks out Against Takeda Pharma-Shire Deal

The opposition to Takeda Pharmaceutical acquiring Shire has taken on another dimension with a prominent member of the family that created the Japanese pharmaceutical company speaking publicly against ...

Deal of the Year: Takeda buys Shire

The $62 billion takeout is the largest acquisition of a foreign company in Japan's history, and would transform Takeda into the 9th largest pharma globally.

Takeda shareholders approve $62bn Shire acquisition http://bit.ly/2E5Igif  #Takeda #Shire #stockmarket #pharma

Takeda shareholders approve $62bn Shire acquisition http://bit.ly/2E5Igif  #Takeda #Shire #stockmarket #pharma

Eisai, Takeda and GARDP hunt for new antibiotics

The not-for-profit Global Antibiotic Research and Development Partnership has joined forces with Eisai and Takeda to search for new antibiotics. Under a new agreement the Japanese pharma companies wi...

leon-nanodrugs Supports Takeda in a Feasibility Assessment of leon’s Proprietary MicroJet Reactor (MJR®) Nano-Technology

Munich, Germany, July 17, 2018 / B3C newswire / -- leon-nanodrugs GmbH (“leon”) is pleased to announce that its proprietary MicroJet Reactor (MJR®) nano-technology has been selected by Takeda Ph...

Takeda shareholders approve $62bn Shire acquisition

Japanese firm Takeda have gained shareholders’ approval for the $62 billion acquisition of the Irish headquartered company Shire Plc. The deal is set to see Asia’s largest pharma firm become a maj...

PubMed Articles [41 Associated PubMed Articles listed on BioPortfolio]

Measurement of three-dimensional wavefronts using the Ichikawa-Lohmann-Takeda solution to the irradiance transport equation.

In this paper, we use the irradiance transport equation and the Fourier transform-based experimental solution given by Ichikawa-Lohmann-Takeda. We analyze experimental factors such as the digital filt...

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Clinical trials go virtual, big pharma dives in.

Disease awareness advertising (DAA) in emerging economy: A comparison between views of consumers and pharmaceutical professionals.

Research on effectiveness of DAA is limited. Existing researches explore impact of DAA only on relationship between drug manufacturers and consumers. However, in reality, pharma marketing revolves aro...

21 Century Citizen Pharma: The FDA & Patient-Focused Product Development.

Perpetual debate regarding the delicate balance between access and innovation and the protection of the public health and safety dominate discussions of the United States Food and Drug Administration ...

Clinical Trials [131 Associated Clinical Trials listed on BioPortfolio]

A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Dexlansoprazole from Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant...

Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing Plants

The purpose of this study is to assess the bioavailability of dexlansoprazole from a 30 milligram (mg) or 60 mg delayed-release capsule manufactured at Takeda GmbH Plant Oranienburg, Germa...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects

The purpose of this study is to confirm a significant influence of ezetimibe and sirolimus on each others pharmacokinetics

Companies [1326 Associated Companies listed on BioPortfolio]

Takeda Pharma GmbH

Nil

Takeda San Francisco, Inc.

Takeda San Francisco, Inc. (TSF), established in November 2007 as a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Osaka, Japan, is Takeda's Biologics Center of Excellence and Antib...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

Takeda Pharmaceuticals International, Inc.

Located in Deerfield, Illinois, Takeda Pharmaceuticals International, Inc. is a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, an industry leader and the larges...

Takeda San Francisco Inc.

Takeda San Francisco was established in November 2007 and supports Takeda's therapeutic antibody research aiming to build antibody technology platforms based on technologies such as discovery and ...

More Information about "Takeda Pharma GmbH" on BioPortfolio

We have published hundreds of Takeda Pharma GmbH news stories on BioPortfolio along with dozens of Takeda Pharma GmbH Clinical Trials and PubMed Articles about Takeda Pharma GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Takeda Pharma GmbH Companies in our database. You can also find out about relevant Takeda Pharma GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record